Cefadroxil/Trimethoprim

头孢羟氨/甲氧苄啶

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCefadroxil/Trimethoprim
Drug Alias Name头孢羟氨苄甲氧苄啶片
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsDihydrofolate reductase inhibitors
TargetsBacterial penicillin-binding proteinDihydrofolate reductase
Therapy Area/IndicationsInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes CefadroxilTrimethoprim
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A